Skip to content

A randomized controlled clinical trial of transcranial magnetic stimulation for vestibular migraine

Clinical efficacy and mechanism of transcranial magnetic stimulation in the treatment of vestibular migraine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097982
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vestibular migraine

Interventions

Experimental group:Neuroregulation by transcranial magnetic stimulation
Control group:Neuroregulation by sham transcranial magnetic stimulation

Sponsors

General Hospital of Xuzhou Mining Group
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Meet the VM diagnostic criteria affirmed in the International Classification of Headache Disorders, Third Edition (ICHD-III); (2) Right-handed, aged 18-60 years old; (3) The frequency of attacks is greater than 4 times per month;

Exclusion criteria

Exclusion criteria: (1) Combined with serious neurological, psychiatric or systemic disease; (2) Have a history of drug abuse or abuse; (3) MMSE14 points or HAMD>17 points; (4) Significant tinnitus and hearing loss; (5) Combined with other vertigo diseases or other types of primary headache; (6) Use of preventive and therapeutic measures other than those prescribed during the study period; (7) Vestibular function examination indicated the presence of external vestibular lesions.

Design outcomes

Primary

MeasureTime frame
Frequency of migraine symptoms;Frequency of vestibular symptoms;Dizziness Handicap Inventory (DHI); Headache Impact Test-6 (HIT-6);

Secondary

MeasureTime frame
Subjective severity of migraine and dizziness;Duration of migraine/dizziness;

Countries

China

Contacts

Public ContactChen Zhengwei

General Hospital of Xuzhou Mining Group

1079372835@qq.com+86 158 9642 0126

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026